322 related articles for article (PubMed ID: 11410522)
1. Multidrug resistance proteins MRP3, MRP1, and MRP2 in lung cancer: correlation of protein levels with drug response and messenger RNA levels.
Young LC; Campling BG; Cole SP; Deeley RG; Gerlach JH
Clin Cancer Res; 2001 Jun; 7(6):1798-804. PubMed ID: 11410522
[TBL] [Abstract][Full Text] [Related]
2. Expression of multidrug resistance protein-related genes in lung cancer: correlation with drug response.
Young LC; Campling BG; Voskoglou-Nomikos T; Cole SP; Deeley RG; Gerlach JH
Clin Cancer Res; 1999 Mar; 5(3):673-80. PubMed ID: 10100721
[TBL] [Abstract][Full Text] [Related]
3. Analysis of expression of cMOAT (MRP2), MRP3, MRP4, and MRP5, homologues of the multidrug resistance-associated protein gene (MRP1), in human cancer cell lines.
Kool M; de Haas M; Scheffer GL; Scheper RJ; van Eijk MJ; Juijn JA; Baas F; Borst P
Cancer Res; 1997 Aug; 57(16):3537-47. PubMed ID: 9270026
[TBL] [Abstract][Full Text] [Related]
4. Expression of the multidrug resistance proteins MRP2 and MRP3 in human hepatocellular carcinoma.
Nies AT; König J; Pfannschmidt M; Klar E; Hofmann WJ; Keppler D
Int J Cancer; 2001 Nov; 94(4):492-9. PubMed ID: 11745434
[TBL] [Abstract][Full Text] [Related]
5. Increased expression of an ATP-binding cassette superfamily transporter, multidrug resistance protein 2, in human colorectal carcinomas.
Hinoshita E; Uchiumi T; Taguchi K; Kinukawa N; Tsuneyoshi M; Maehara Y; Sugimachi K; Kuwano M
Clin Cancer Res; 2000 Jun; 6(6):2401-7. PubMed ID: 10873092
[TBL] [Abstract][Full Text] [Related]
6. Multidrug resistance protein (MRP) activity in normal mature leukocytes and CD34-positive hematopoietic cells from peripheral blood.
Laupèze B; Amiot L; Payen L; Drénou B; Grosset JM; Lehne G; Fauchet R; Fardel O
Life Sci; 2001 Feb; 68(11):1323-31. PubMed ID: 11233999
[TBL] [Abstract][Full Text] [Related]
7. Increased expression of multidrug resistance-associated proteins in bladder cancer during clinical course and drug resistance to doxorubicin.
Tada Y; Wada M; Migita T; Nagayama J; Hinoshita E; Mochida Y; Maehara Y; Tsuneyoshi M; Kuwano M; Naito S
Int J Cancer; 2002 Apr; 98(4):630-5. PubMed ID: 11920626
[TBL] [Abstract][Full Text] [Related]
8. Expression of the multidrug resistance proteins MRP2 and MRP3 in human cholangiocellular carcinomas.
Rau S; Autschbach F; Riedel HD; Konig J; Kulaksiz H; Stiehl A; Riemann JF; Rost D
Eur J Clin Invest; 2008 Feb; 38(2):134-42. PubMed ID: 18226047
[TBL] [Abstract][Full Text] [Related]
9. Characterization of the 5'-flanking region of the human multidrug resistance protein 2 (MRP2) gene and its regulation in comparison withthe multidrug resistance protein 3 (MRP3) gene.
Stöckel B; König J; Nies AT; Cui Y; Brom M; Keppler D
Eur J Biochem; 2000 Mar; 267(5):1347-58. PubMed ID: 10691972
[TBL] [Abstract][Full Text] [Related]
10. Involvement of the multidrug resistance protein 3 in drug sensitivity and its expression in human glioma.
Haga S; Hinoshita E; Ikezaki K; Fukui M; Scheffer GL; Uchiumi T; Kuwano M
Jpn J Cancer Res; 2001 Feb; 92(2):211-9. PubMed ID: 11223551
[TBL] [Abstract][Full Text] [Related]
11. Expression of multidrug resistance-associated protein 2 is involved in chemotherapy resistance in human pancreatic cancer.
Noma B; Sasaki T; Fujimoto Y; Serikawa M; Kobayashi K; Inoue M; Itsuki H; Kamigaki M; Minami T; Chayama K
Int J Oncol; 2008 Dec; 33(6):1187-94. PubMed ID: 19020751
[TBL] [Abstract][Full Text] [Related]
12. Doxorubicin induces expression of multidrug resistance-associated protein 1 in human small cell lung cancer cell lines by the c-jun N-terminal kinase pathway.
Shinoda C; Maruyama M; Fujishita T; Dohkan J; Oda H; Shinoda K; Yamada T; Miyabayashi K; Hayashi R; Kawagishi Y; Fujita T; Matsui S; Sugiyama E; Muraguchi A; Kobayashi M
Int J Cancer; 2005 Oct; 117(1):21-31. PubMed ID: 15880572
[TBL] [Abstract][Full Text] [Related]
13. Cells from chronic myelogenous leukaemia patients at presentation exhibit multidrug resistance not mediated by either MDR1 or MRP1.
Carter A; Dann EJ; Katz T; Shechter Y; Oliven A; Regev R; Eytan E; Rowe JM; Eytan GD
Br J Haematol; 2001 Sep; 114(3):581-90. PubMed ID: 11552983
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical expression of MRP2 and clinical resistance to platinum-based chemotherapy in small cell lung cancer.
Ushijima R; Takayama K; Izumi M; Harada T; Horiuchi Y; Uchino J; Hara N; Nakanishi Y
Anticancer Res; 2007; 27(6C):4351-8. PubMed ID: 18214043
[TBL] [Abstract][Full Text] [Related]
15. Transport of ethinylestradiol glucuronide and ethinylestradiol sulfate by the multidrug resistance proteins MRP1, MRP2, and MRP3.
Chu XY; Huskey SE; Braun MP; Sarkadi B; Evans DC; Evers R
J Pharmacol Exp Ther; 2004 Apr; 309(1):156-64. PubMed ID: 14722317
[TBL] [Abstract][Full Text] [Related]
16. ATP-binding cassette superfamily transporter gene expression in human primary ovarian carcinoma.
Ohishi Y; Oda Y; Uchiumi T; Kobayashi H; Hirakawa T; Miyamoto S; Kinukawa N; Nakano H; Kuwano M; Tsuneyoshi M
Clin Cancer Res; 2002 Dec; 8(12):3767-75. PubMed ID: 12473588
[TBL] [Abstract][Full Text] [Related]
17. Induction of MRP5 and SMRP mRNA by adriamycin exposure and its overexpression in human lung cancer cells resistant to adriamycin.
Yoshida M; Suzuki T; Komiya T; Hatashita E; Nishio K; Kazuhiko N; Fukuoka M
Int J Cancer; 2001 Nov; 94(3):432-7. PubMed ID: 11745426
[TBL] [Abstract][Full Text] [Related]
18. Multidrug resistance associated genes MRP1, MRP2 and MRP3 in primary and anthracycline exposed breast cancer.
Faneyte IF; Kristel PM; van de Vijver MJ
Anticancer Res; 2004; 24(5A):2931-9. PubMed ID: 15517899
[TBL] [Abstract][Full Text] [Related]
19. Expression of breast cancer resistance protein is associated with a poor clinical outcome in patients with small-cell lung cancer.
Kim YH; Ishii G; Goto K; Ota S; Kubota K; Murata Y; Mishima M; Saijo N; Nishiwaki Y; Ochiai A
Lung Cancer; 2009 Jul; 65(1):105-11. PubMed ID: 19036469
[TBL] [Abstract][Full Text] [Related]
20. Role of RLIP76 in lung cancer doxorubicin resistance: II. Doxorubicin transport in lung cancer by RLIP76.
Awasthi S; Singhal SS; Singhal J; Cheng J; Zimniak P; Awasthi YC
Int J Oncol; 2003 Apr; 22(4):713-20. PubMed ID: 12632060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
